Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Rapid7, Inc is a software-application business based in the US. Rapid7 shares (RPD) are listed on the NASDAQ and all prices are listed in US Dollars. Rapid7 employs 1,847 staff and has a trailing 12-month revenue of around USD$411.5 million.
Our top pick for
Beginners
Our top pick for
Active investors
Our top pick for
Building a portfolio
52-week range | USD$31.3401 - USD$94.596 |
---|---|
50-day moving average | USD$86.1453 |
200-day moving average | USD$73.6599 |
Wall St. target price | USD$102.46 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-1.048 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$411.5 million |
---|---|
Gross profit TTM | USD$290 million |
Return on assets TTM | -5.62% |
Return on equity TTM | -127.79% |
Profit margin | -24.02% |
Book value | $1.37 |
Market capitalisation | USD$4.3 billion |
TTM: trailing 12 months
There are currently 5.5 million Rapid7 shares held short by investors – that's known as Rapid7's "short interest". This figure is 2.2% down from 5.7 million last month.
There are a few different ways that this level of interest in shorting Rapid7 shares can be evaluated.
Rapid7's "short interest ratio" (SIR) is the quantity of Rapid7 shares currently shorted divided by the average quantity of Rapid7 shares traded daily (recently around 464382.11586902). Rapid7's SIR currently stands at 11.91. In other words for every 100,000 Rapid7 shares traded daily on the market, roughly 11910 shares are currently held short.
However Rapid7's short interest can also be evaluated against the total number of Rapid7 shares, or, against the total number of tradable Rapid7 shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Rapid7's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Rapid7 shares in existence, roughly 110 shares are currently held short) or 0.108% of the tradable shares (for every 100,000 tradable Rapid7 shares, roughly 108 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Rapid7.
Find out more about how you can short Rapid7 stock.
We're not expecting Rapid7 to pay a dividend over the next 12 months.
Over the last 12 months, Rapid7's shares have ranged in value from as little as $31.3401 up to $94.596. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rapid7's is 1.2935. This would suggest that Rapid7's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Rapid7, Inc. provides cyber security solutions. The company offers a cloud-native insight platform that enable customers to create and manage analytics-driven cyber security risk management programs. Its platform include vulnerability management solutions comprising InsightVM that is designed to provide a way to collect vulnerability data, prioritize risk, and automate remediation; InsightIDR, an incident detection and response solution; InsightAppSec provides application security testing that analyzes web applications for security vulnerabilities; and InsightConnect, a SOAR solution that is used by security professionals. The company's other products include Nexpose, an on-premise version of company's vulnerability risk management solution; AppSpider, an on-premise version of company's application security testing solution; Metasploit, a penetration testing software solution; and InsightOps that enables organizations to store and search data in real time. It offers its products through a combination of perpetual and term software licenses, cloud-based subscriptions, and managed services. The company serves customers in a range of industries, including technology, energy, financial services, healthcare and life sciences, manufacturing, media and entertainment, retail, education, real estate, transportation, government, and professional services industries through sales teams, and indirect channel partner relationships, as well as directly in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It has a strategic partnership with Snyk to deliver end-to-end application security to organizations developing cloud native applications. Rapid7, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.